Live from the NIH registry
Studies recruiting near Kissimmee right now
Top 25 of 914 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (16.3 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Clermont, Florida (27.5 mi)
· Sponsor: AstraZeneca
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
AdventHealth — Altamonte Springs, Florida (24.9 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Winter Park, Florida (21.0 mi)
· Sponsor: Alkermes, Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Pediatric Neurology & Epilepsy Center Of Central Florida - Winter Park /ID# 275263 — Winter Park, Florida (21.0 mi)
· Sponsor: AbbVie
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Orlando, Florida (16.3 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
AdventHealth Orlando — Orlando, Florida (16.3 mi)
· Sponsor: Eli Lilly and Company
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (16.3 mi)
· Sponsor: Giselle Sholler
Improving Mechanics and Confidence in the Hip Hinge
Hip Hinge, Hip and Knee Movement
N/A
Interventional 30 participants sought
University of Central Florida — Orlando, Florida (16.3 mi)
· Sponsor: University of Central Florida
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona — Orlando, Florida (16.3 mi)
· Sponsor: Bayer
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Central Florida Pulmonary Group, P.A. — Orlando, Florida (16.3 mi)
· Sponsor: Philip Morris Products S.A.
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Endoscopic Research Inc — Orlando, Florida (16.3 mi)
· Sponsor: Takeda
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Central Florida Kidney Specialists — Orlando, Florida (16.3 mi)
· Sponsor: Calliditas Therapeutics AB
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Colitis Ulcerative
Phase 2
Interventional 204 participants sought
Clinical Research of Osceola- Site Number : 8400012 — Kissimmee, Florida (0.0 mi)
· Sponsor: Sanofi
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Orlando Health — Orlando, Florida (16.3 mi)
· Sponsor: Analog Device, Inc.
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Central Florida Pulmonary Group — Orlando, Florida (16.3 mi)
· Sponsor: Nicole Hamblett
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
Neurology Associates, P. A. — Maitland, Florida (22.6 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Orlando Health Heart and Vascular Institute — Orlando, Florida (16.3 mi)
· Sponsor: Biosense Webster, Inc.
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3
Interventional 59 participants sought
Neurology Associates — Maitland, Florida (22.6 mi)
· Sponsor: Takeda
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
Healthy Volunteer Study, Hepatic Impairment
Phase 1
Interventional 28 participants sought
Atea Study Site — Orlando, Florida (16.3 mi)
· Sponsor: Atea Pharmaceuticals, Inc.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Orlando, Florida (16.3 mi)
· Sponsor: Avenzo Therapeutics, Inc.
Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants
Severe Hepatic Impairment, Normal Hepatic Function
Phase 1
Interventional 20 participants sought
Orlando Clinical Research Center — Orlando, Florida (16.3 mi)
· Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
Charter Research — Winter Park, Florida (21.0 mi)
· Sponsor: Lantheus Biosciences Ltd.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Clermont Oncology Center ( Site 0046) — Clermont, Florida (27.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 200 participants sought
Neurocrine Clinical Site — Maitland, Florida (22.6 mi)
· Sponsor: Neurocrine Biosciences